Furthermore, it would be advantageous to repurpose PI3K inhibitors as adjuvants for bacterial infections with the extensive amount of research and development into inhibitors of class 1 PI3Ks as cancer therapeutics (Leahy et al., 2012). Here, PIK3CD is linked to cancer.